Concomitant <i>PIK3CA</i> and <i>TP53</i> Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis-Reference-Cited by-同舟云学术

Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis

Published:2023 Issue:4 Volume:26 Page:363
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Lin Xiao-Yi¹²^ORCID,Guo Lijuan¹³^ORCID,Lin Xin¹⁴^ORCID,Wang Yulei¹^ORCID,Zhang Guochun¹^ORCID

Affiliation:

1. Department of Breast Surgery, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.

2. Shantou University Medical College, Shantou, Guangdong, China.

3. School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.

4. The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.

Funder

National Natural Science Foundation of China

Guangzhou Municipal Science and Technology Project

Natural Science Foundation of Guangdong Province

Basic and Applied Basic Research Foundation of Guangdong Province

Administration of Traditional Chinese Medicine of Guangdong Province

Publisher

XMLink

Subject